University of Hartford

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Hartford sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials 2 currently recruiting 11 completed top decile by trial count

University of Hartford: 14 sponsored US clinical trials, 2 recruiting.

University of Hartford sponsors 14 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 11 completed. The most-studied condition in this pipeline is Chronic Low Back Pain, with 1 trials.

Top-decile sponsor footprint

University of Hartford ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

11 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

14 total, page 1 of 1

RECRUITING NA

The Effects of Brief Periods of Exercise on Blood Pressure

NCT07453550
RECRUITING NA

Transcutaneous Electrical Nerve Stimulation (TENS) and Low Back Pain

NCT05812885
COMPLETED NA

High Intensity Exercise and Improving Physical Activity Among People With Neurologic Dysfunction

NCT06945835
COMPLETED NA

The Combined Effect of TENS and TaVNS on Pressure and Heat Pain Thresholds in Pain-Free Subjects

NCT06361381
COMPLETED NA

Validation of the Cervicothoracic Differentiation Test

NCT06287242
COMPLETED NA

Kids Rehydration During Exercise

NCT05989607
COMPLETED NA

Spine Position and Neural Sensitivity

NCT05313217
COMPLETED NA

Combined Effects of Manual Therapy on the Shoulder

NCT04777370
COMPLETED

Lateral Neck Flexor Endurance and Hyperlaxity

NCT04770987
TERMINATED NA

Training Balance Among People With Neurodevelopmental Disabilities

NCT04293120
COMPLETED NA

Effects of Manual Therapy on Shoulder Function

NCT04513535
COMPLETED NA

Effect of Trunk Support on Academic Engagement of Children With Severe Disability

NCT05391594
COMPLETED NA

EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety

NCT02964520
COMPLETED NA

Case Series_Targeted Training for Trunk Control Cerebral Palsy

NCT02246751

Therapeutic Areas

Chronic Low Back Pain 1
Neck Pain 1
Anxiety 1

What is open in the University of Hartford pipeline

2 recruiting of 14 indexed (14% open); 11 completed (79%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Chronic Low Back Pain (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Hartford: open-pipeline peers nationwide

Peers matched on 14 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

University of Hartford sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%5%10%15%20% Total trials Recruiting share University of Hartford3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USAAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
University of Hartford sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Hartford sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Hartford page

14 registered trials is a research-attention snapshot, not an endorsement of University of Hartford or any single study.

  • 2 of University of Hartford's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Chronic Low Back Pain is the condition University of Hartford studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Hartford pipeline card: 14 registered trials from official public datasets.Report a data error.